We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Advanced approach - Early implant placement

Early implant placement may offer advantages in terms of soft and hard tissue preservation results1. When this therapy option is combined with simultaneous augmentation using Geistlich Bio-Oss® or Geistlich Bio-Oss® Collagen and Geistlich Bio-Gide®, predictable results can be expected2.

Sealing the socket with Geistlich Mucograft® Seal can further improve soft-tissue parameters in extraction sockets with preserved buccal walls2.

 

Clinical case: Early implant placement with GBR after spontaneous healing. 

 

Early implant placement in combination with simultaneous ridge contour augmentation using Geistlich Bio-Oss® and Geistlich Bio-Gide® leads to pleasing aesthetic outcome3.

Clinical case: Early implant placement with socket sealing for improvement of soft-tissue parameters.

 

The use of Geistlich Bio-Oss® Collagen and Geistlich Mucograft® Seal minimises invasion and maximises soft-tissue outcomes2.

 

References:

  1. Sanz M, et al.: Clin Oral Implants Res 2012; 23 Suppl 5: 67-79 (systematic review - based on clinical studies).
  2. Geistlich Mucograft Seal Advisory Board Meeting Report, 2013. Data on file Geistlich Pharma AG, Wolhusen, Switzerland.
  3. Buser D, et al.: J Periodontol 2011; 82: 342-49 (clinical study).

 

 

Verena Vermeulen
Group Lead Clinical Marketing